Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28874362.
- Also identified by DOI 10.1136/bmj.j3545 and PMC identifier 5582343.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malaria, tuberculosis, and HIV present unique challenges in the control of antimicrobial resistance, and require targeted policies, say <b>Samiran Panda and colleagues</b>
Medical subject headings
- Anti-Infective Agents
- Anti-Infective Agents/therapeutic use
- Asia, Southeastern
- Asia, Southeastern/epidemiology
- Drug Resistance, Microbial
- HIV Infections
- HIV Infections/drug therapy
- HIV Infections/epidemiology
- Humans
- Malaria
- Malaria/drug therapy
- Malaria/epidemiology
- Tuberculosis
- Tuberculosis/drug therapy
- Tuberculosis/epidemiology